Inhibition of the de-myelinating properties of Aicardi-Goutières Syndrome lymphocytes by cathepsin D silencing

Alessandra Pulliero(University of Genoa), Alberto Izzotti, Cinzia Domenicotti(University of Genoa), Ivana Olivieri(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Barbara Marengo(University of Genoa), Elisa Fazzi(Urology Foundation), Umberto Balottin(University of Pavia), Simona Orcesi(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), M. LONGOBARDI(University of Genoa), Cristina Cereda(University of Milan)
Biochemical and Biophysical Research Communications
December 19, 2012
10.1016/j.bbrc.2012.11.131
Cited by 9

Related Papers

Role of Glutathione in Cancer Progression and Chemoresistance
|Oxidative Medicine and Cellular Longevity|2013|1.2k
Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection
|Nature Genetics|2006|673
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
|Nature Genetics|2021|567
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
|The Lancet Neurology|2013|441